OKYO Pharma announced that Chief Executive Officer Robert J. Dempsey will present at the Stifel 2026 Healthcare Conference on November 12, 2026, in New York. The company's leadership team will also hold one-on-one investor meetings during the event, which runs from November 10 to 12. A live webcast of the presentation will be available via Stifel and archived for 90 days on OKYO's website. OKYO Pharma is a clinical-stage biopharmaceutical company developing investigational therapies for neuropathic corneal pain and anterior segment eye diseases.
